CoChat

Inhibition of Telomerase Activity by Human Immunodeficiency Virus (HIV) Nucleos(t)ide Reverse Transcriptase Inhibitors: A Potential Factor Contributing to HIV-Associated Accelerated Aging

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Human immunodeficiency virus (HIV)-infected patients on combination active antiretroviral therapy (cART) are at increased risk of age-related complications. We hypothesized that nucleos(t)ide reverse transcriptase inhibitors (NRTI) may contribute to accelerated aging in HIV-infected individuals on cART via inhibition of telomerase activity. METHODS: Telomerase activity and telomere length (TL) were measured by quantitative polymerase chain reaction in vitro in activated peripheral blood mononuclear cells (PBMCs) cultured with NRTI and ex vivo in PBMCs from uninfected patients exposed to NRTI and from HIV-infected patients on NRTI-containing cART. RESULTS: Lamivudine, abacavir, zidovudine, emtricitabine, and tenofovir significantly inhibited telomerase activity in activated PBMCs in vitro. Tenofovir was the most potent inhibitor of telomerase activity and caused greatest shortening of TL in vitro at the therapeutic concentration of 0.3 μM. PBMCs from HIV-infected patients receiving NRTI-containing cART (n = 39) had significantly lower telomerase activity than HIV-uninfected patients (n = 47; P = .011) and HIV-infected patients receiving non-NRTI-containing cART (n = 11; P < .001). TL was significantly inversely associated with age (P = .009) and the total duration on any NRTI (P = .01). CONCLUSIONS: NRTIs and, specifically tenofovir at therapeutic concentrations, inhibit telomerase activity leading to accelerated shortening of TL in activated PBMCs. The relationship between NRTI, reduced telomerase activity, and accelerated aging requires further investigation in HIV-infected individuals on cART.

Overview

Integrity signals

Registry

Crossref · 10.1093/infdis/jit006

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 49 references

Cited by

Metadata

Authors
Leeansyah, E., Cameron, P. U., Solomon, A., Tennakoon, S., Velayudham, P., Gouillou, M., Spelman, T., Hearps, A., Fairley, C., Smit, D. V., Pierce, A. B., Armishaw, J., Crowe, S. M., Cooper, D. A., Koelsch, K. K., Liu, J.-P., Chuah, J., & Lewin, S. R.
Affiliations
  • Burnet Institute (AU)
  • The Alfred Hospital (AU)
  • UNSW Sydney (AU)
  • Griffith University (AU)
Corresponding author
Leeansyah, Edwin
Venue
The Journal of Infectious Diseases
Published
2013-01-09
Volume
207
Issue
7
Pages
1157-1165
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2109413245
Cited by
136
References
50
Citations by year
2026: 4 · 2025: 6 · 2024: 8 · 2023: 4 · 2022: 8 · 2021: 13 · 2020: 13 · 2019: 11 · 2018: 15 · 2017: 10 · 2016: 9 · 2015: 7 · 2014: 17 · 2013: 11
FWCI
10.90
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Griffith Research Online (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Keywords
HIV, telomerase inhibition, telomere length, accelerated aging, tenofovir, highly active antiretroviral therapy, peripheral blood mononuclear cells, zidovudine, lamivudine, abacavir, emtricitabine
MeSH terms
Emtricitabine, Tenofovir, Abacavir, Adenine, Adult, Aging, Cells, Cultured, Deoxycytidine, Enzyme Activation, Female, HIV, Humans, Leukocytes, Mononuclear, Male, Middle Aged, Regression Analysis, Risk Factors, Time Factors, Zidovudine, Dideoxynucleosides, HIV Infections, Case-Control Studies, Polymerase Chain Reaction, Telomere, Reverse Transcriptase Inhibitors, Telomerase, Lamivudine, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Young Adult, Telomere Shortening, Organophosphonates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.